Which of the statements below about the history of paroxysmal nocturnal hemoglobinuria (PNH) are correct? Select one of the options for each question, then submit your answers to see how well you ...

Because systemic mastocytosis can appear to be various other hematologic disorders, correct diagnosis requires thorough clinical and pathological investigation. Physicians from the Medanta†The ...

The new study aims to use advanced imaging to quantify hepatobiliary changes before and after treatment in patients with PBC. A new study is being launched that will use imaging diagnostics to observe ...

Systemic mastocytosis in children often have a distinctive, atypical presentation. In the Borneo Journal of Medical Sciences, physicians presented the case of a child with systemic mastocytosis (SM) ...

In all suspected cases of mast cell activation and degranulation, a timely tryptase measurement is required to confirm anaphylaxis and differentiate it from its mimics. Assessment of elevated baseline ...

Living with Pulmonary Hypertension Physical Dimension scores decreased in all 3 MK-5475 treatment arms, indicating improvements in participants' physical functioning at 12 weeks, whereas the placebo ...

Elevated levels of leukocyte-derived extracellular vesicles and red blood cell-derived extracellular vesicles are independent risk factors for PAH in patients with SLE. Elevated levels of specific ...

Concurrent sarcopenia, severe pruritus, and systemic oxidative stress imbalances in PBC can significantly reduce quality of life. In patients with primary biliary cholangitis (PBC), cholestasis is ...

Employing liver stiffness measurements, splenic area, and periportal hypoechoic band could potentially eliminate 76.6%, 83.8%, and 73.0% of unnecessary endoscopic procedures, respectively. A recent ...

Contrary to expectations, reducing serotonin levels via rodatristat ethyl led to worse pulmonary vascular resistance and more adverse events. Results from the ELEVATE-2 clinical trial show that ...

Pulmonary rehabilitation via exercise is effective but is often interrupted by hospitalizations in lung transplant candidates with PAH. A new study has observed safety and efficacy of pulmonary ...

Following the initial approval of ruxolitinib in 2011, three additional agents have been approved: fedratinib, pacritinib, and momelotinib. Several janus kinase (JAK) inhibitors have been approved for ...